Articles by Disease (Hematological Malignancies)

HtrA Serine Proteases as Potential Therapeutic Targets in Cancer

Journal: Current Cancer Drug Targets
Volume: 9
Page: 451-468
Author(s): Jeremy Chien, Mara Campioni, Viji Shridhar and Alfonso Baldi

Exposure of B Cell Chronic Lymphocytic Leukemia (B-CLL) Cells to Nutlin-3 Induces a Characteristic Gene Expression Profile, which Correlates with Nutlin-3-Mediated Cytotoxicity (Supplementry Table)

Journal: Current Cancer Drug Targets
Volume: 9
Page: 510-518
Author(s): G. Zauli, M. G. di Iasio, P. Secchiero, M. Dal Bo, D. Marconi, R. Bomben, G. Del Poeta and V. Gattei

Treatment of Inflammatory Diseases with Mesenchymal Stem Cells

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 8
Page: 110-123
Author(s): Robert E. Newman, Dana Yoo, Michelle A. LeRoux and Alla Danilkovitch-Miagkova

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9
Page: 113-131
Author(s): Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti

RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9
Page: 741-748
Author(s): Travis W. Day and Ahmad R. Safa

Thalidomide Chemotherapy-Induced Peripheral Neuropathy: Actual Status and New Perspectives with Thalidomide Analogues Derivatives

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9
Page: 760-768
Author(s): Sante Cundari and Guido Cavaletti

Clofarabine as a Novel Nucleoside Analogue Approved to Treat Patients with Haematological Malignancies: Mechanism of Action and Clinical Activity

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9
Page: 805-812
Author(s): Ewa Lech-Maranda, Anna Korycka and Tadeusz Robak